首页 | 本学科首页   官方微博 | 高级检索  
     


Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia
Authors:M Misago  N Mori  T Hoshuyama  J Tsukada  I Morimoto  S Oda  S Chiba  S Eto
Affiliation:First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health.
Abstract:A 69-year-old female was admitted for pancytopenia. The hematological examination showed leukocytes 1,800/microliters, hemoglobin 5.3 g/dl and platelets 9.6 x 10(4)/microliters. A bone marrow aspiration revealed hypoplasia, but no abnormal cells. Serum erythropoietin titer was 5,100 mU/ml. Diagnosis of aplastic anemia was made. She received 400 ml of blood transfusion twice, and was then treated with recombinant human erythropoietin (rHuEPO) (12,000 U/day) three times a week for eight weeks. Hemoglobin level gradually increased to the level of 12.0 g/dl. This case suggests that there are some cases of aplastic anemia which can respond to treatment with rHuEPO.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号